Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) — Capital Reinvestment Ratio
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) has a Capital Reinvestment Ratio of 0.68x as of December 2025, meaning it reinvests 1% of its operating cash flow ($41.05 Million) in capital expenditures ($27.77 Million). See ZYBT net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhengye Biotechnology Holding Limited Ordinary Shares Capital Reinvestment Ratio (2021–2025)
This chart tracks Zhengye Biotechnology Holding Limited Ordinary Shares's Capital Reinvestment Ratio across 5 annual periods. Check ZYBT cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Zhengye Biotechnology Holding Limited Ordinary Shares (2021–2025)
Year-by-year Capital Reinvestment Ratio for Zhengye Biotechnology Holding Limited Ordinary Shares from 2021 to 2025. For live market cap and broader valuation context, see Zhengye Biotechnology Holding Limited Or (ZYBT) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.68x | $41.05 Million | $27.77 Million | ▲ +0.0% |
| 2024 | 0.68x | $41.05 Million | $27.77 Million | ▲ +181.1% |
| 2023 | 0.24x | $48.18 Million | $11.60 Million | ▼ -84.7% |
| 2022 | 1.58x | $17.34 Million | $27.33 Million | ▲ +89.9% |
| 2021 | 0.83x | $31.81 Million | $26.40 Million | — |